Left Ventricular Remodeling

2

Review clinical trials related to Left Ventricular Remodeling. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cold-Region Exposure and Cardiac Remodeling After PCI

This multicenter prospective observational cohort study aims to investigate the association between cumulative cold-region exposure and adverse left ventricular remodeling and cardiovascular outcomes in patients with coronary artery disease undergoing successful percutaneous coronary intervention (PCI). Individual-level chronic cold exposure will be quantified primarily by cumulative months of residence, work, or other relevant exposure in cold regions during the 3 years preceding PCI. Additional exposure measures will include regional cold-wave days derived from meteorological records and winter outdoor occupational exposure. Participants will undergo baseline cardiovascular magnetic resonance (CMR), echocardiography, electrocardiography, and clinical and laboratory assessment after PCI. Echocardiography will be repeated at 6 months to assess left ventricular remodeling. Cardiovascular events will be prospectively collected during follow-up. The study will evaluate whether cumulative cold-region exposure is associated with distinct CMR phenotypes, adverse left ventricular remodeling, and major adverse cardiovascular events (MACE), and whether cold-exposure measures provide incremental prognostic information beyond conventional clinical, imaging, and electrocardiographic risk markers.

Participants needed: 400
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Chinese PLA General HospitalUpdated: Aug 19, 2026Locations: 1Duration: 12 Months
Eligibility criteria

Age 18 to 75 years. Angiographically confirmed coronary artery disease treated w...

Severe valvular heart disease, cardiomyopathy, congenital heart disease, or othe...

Status: Recruiting

Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis

To identify plasma multi-omics biomarkers that predict left ventricular adverse remodeling (LVAR) and major adverse cardiovascular events (MACE) in patients with acute ST-segment elevation myocardial infarction, and to investigate the molecular pathways linked to LVAR and MACE.

Participants needed: 1,000
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Beijing Anzhen HospitalUpdated: May 12, 2026Locations: 1
Eligibility criteria

Age ≥18 years and ≤80 years. [+6]

Non-atherosclerotic MI: coronary embolism, spasm, aortic dissection, myocarditis... [+14]